Laboratory-Grade Peptides & SARMs for Scientific Research

Executive Research Study Stack includes:

2 Ipamorelin 5mg

1 Retatrutide 10mg

1 MK677 25mg/ml, 30ml

1 Ostarine 25mg/ml, 30ml

1 Cardarine 20mg/ml, 30ml

4 TB500 5mg

Executive Research Study Stack – At EliteBiogenix, we provide high-purity research compounds designed exclusively for scientific investigation into growth hormone stimulation, metabolic enhancement, tissue repair, and anti-aging mechanisms. Our Executive Research Study Stack — Ipamorelin, Retatrutide, MK-677, Ostarine, Cardarine, and TB500—are strictly for in vitro and preclinical research purposes only and are not for human or veterinary use.

Each compound in the Executive Research Study Stack is third-party tested for purity and potency, ensuring reliable results for researchers studying:
✔ Growth hormone (GH) secretion & IGF-1 modulation
✔ Muscle preservation & fat metabolism
✔ Tissue regeneration & anti-aging pathways
✔ Metabolic & endurance enhancement

Below, we provide a detailed scientific breakdown of each compound included in the Executive Research Study Stack, including:

• Mechanisms of action

• Key research benefits

• PubMed-linked studies with dosages used

• Optimal research applications

1. Ipamorelin – Selective Growth Hormone Secretagogue (GHS) for Anti-Aging Research

Executive Research Study Stack – Mechanism of Action

Ipamorelin is a pentapeptide that selectively stimulates GH release via ghrelin receptor (GHSR-1a) activation, mimicking natural pulsatile GH secretion without affecting cortisol or prolactin.

Executive Research Study Stack – Research Benefits & Key Studies

• Stimulates GH/IGF-1 secretion (Study: 100–200 mcg/kg in rats, PubMed)

• Preserves lean mass in catabolic states (Study: 0.1 mg/kg in muscle atrophy models, PubMed)

• Enhances collagen synthesis & wound healing (Study: 1 mg/kg in dermal repair models, PubMed)

Executive Research Study Stack – Suggested Research Dosages

• In vitro studies: 10–100 nM concentrations

• Preclinical models: 0.1–0.3 mg/kg/day

Best for: Research on age-related GH deficiency, sarcopenia, and tissue regeneration.

2. Retatrutide (LY3437943) – Triple-Agonist for Metabolic & Longevity Studies

Executive Research Study Stack – Mechanism of Action

Retatrutide is a GLP-1/GIP/glucagon receptor triple agonist that promotes fat loss, glucose control, and potential lifespan extension via AMPK/mTOR pathways.

Executive Research Study Stack – Research Benefits & Key Studies

• Reduces adiposity by 24% in obese models (Study: 0.3 mg/kg in primates, PubMed)

• Improves insulin sensitivity (Study: 0.1–0.5 mg/kg in diabetic rodents, PubMed)

• Activates mitochondrial biogenesis (Study: 0.2 mg/kg in aging models, PubMed)

Suggested Research Dosages

• Metabolic studies: 0.1–0.5 mg/kg, 2–3x/week

• Longevity research: Low-dose chronic exposure (0.05 mg/kg/day)

Best for: Investigations into obesity, type 2 diabetes, and caloric restriction mimetics.

3. MK-677 (Ibutamoren) – Oral Ghrelin Agonist for GH/IGF-1 Research

Executive Research Study Stack – Mechanism of Action

MK-677 is an oral ghrelin mimetic that increases IGF-1 levels by 60%+ by stimulating pituitary GH release.

Executive Research Study Stack – Research Benefits & Key Studies

• Elevates IGF-1 for 24+ hours (Study: 10–25 mg/day in humans, PubMed)

• Preserves muscle in atrophy models (Study: 0.5–2 mg/kg in rodents, PubMed)

• Improves sleep architecture (Study: 10 mg in elderly subjects, PubMed)

Suggested Research Dosages

• Preclinical studies: 0.5–2 mg/kg/day

• Dosing frequency: Once daily (oral administration)

Best for: Research on sarcopenia, sleep disorders, and GH-deficient aging.

4. Ostarine (MK-2866) – SARM for Muscle Preservation Research

Executive Research Study Stack – Mechanism of Action

Ostarine selectively activates androgen receptors in muscle/bone, promoting anabolism without androgenic side effects.

Executive Research Study Stack – Research Benefits & Key Studies

• Prevents muscle wasting (Study: 1 mg/kg in atrophy models, PubMed)

• Increases bone mineral density (Study: 0.3 mg/kg in osteoporosis models, PubMed)

Suggested Research Dosages

• Muscle atrophy studies: 0.3–1 mg/kg/day

• Chronic dosing: 8–12 weeks in preclinical models

Best for: Studies on sarcopenia, osteoporosis, and androgen receptor modulation.

5. Cardarine (GW501516) – PPARδ Agonist for Fat Metabolism & Endurance

Executive Research Study Stack – Mechanism of Action

Cardarine activates PPARδ, shifting metabolism toward fat oxidation and mitochondrial biogenesis.

Executive Research Study Stack – Research Benefits & Key Studies

• Increases endurance by 70%+ (Study: 2.5 mg/kg in rodents, PubMed)

• Reduces adiposity without catabolism (Study: 1–5 mg/kg in obese models, PubMed)

Suggested Research Dosages

• Metabolic studies: 1–5 mg/kg/day

• Endurance research: Acute dosing pre-exercise

Best for: Investigations into obesity, metabolic syndrome, and exercise performance.

6. TB500 – Regenerative Peptide for Tissue Repair Studies

Executive Research Study Stack – Mechanism of Action

TB500 (thymosin β4 fragment) promotes cell migration, angiogenesis, and anti-fibrotic effects.

Executive Research Study Stack – Research Benefits & Key Studies

• Accelerates muscle repair (Study: 2–6 mg/kg in injury models, PubMed)

• Reduces cardiac fibrosis (Study: 4 mg/kg post-MI, PubMed)

Suggested Research Dosages

• Acute injury models: 2–6 mg/kg, 2x/week

• Chronic degeneration: 1–2 mg/kg, 3x/week

Best for: Research on tendon/ligament repair, myocardial injury, and age-related fibrosis.

Why Researchers Trust EliteBiogenix

✔ HPLC-verified purity (≥98%)
✔ Strictly for lab use (no human/veterinary application)
✔ Optimized formulations for reliable results
✔ Fast USA shipping & bulk discounts

Executive Research Study Stack – Order Now for Your Research!

Explore our catalog at EliteBiogenix.is and elevate your studies with pharmaceutical-grade compounds.

Disclaimer: These products are for research purposes only. By purchasing, you confirm compliance with all applicable laws and institutional guidelines.